Dr. Lisa Mathew interviews Dr. Sahil Patel and Patrick Leonard of SideBy Care, a virtual platform that partners with GI practices to support patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia.







SideBy Care provides gut-brain therapy, nutrition counseling, and behavioral support through a multidisciplinary team - services that are typically covered by insurance and integrate seamlessly into existing GI practice workflows.



Join Dr. Mathew, Dr. Patel, and Patrick Leonard as they explore how collaboration between gastroenterologists and digital care teams can expand access, improve outcomes, and enhance the patient experience.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 83, presented by TissueCypher from Castle Biosciences

Dr. Michael Weinstein interviews Dr. Casey Chapman, chief medical officer of the GI Alliance, and Jonathan Ng, founder and CEO of Iterative Health, about a new strategic partnership to expand access to clinical trials across 400 GI Alliance locations in 20 states.







By integrating the GI Alliance's established research sites with Iterative Health’s Site Network, the collaboration creates one of the largest GI-focused research networks in the country.



Dr. Chapman and Mr. Ng highlight how private practice gastroenterology can play a leading role in advancing research by making clinical trials more accessible to patients in community settings.



Join Dr. Weinstein, Dr. Chapman, and Mr. Ng as they explore the growth of clinical research in private practice and how collaboration can advance the field of gastroenterology.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 82, presented by TissueCypher from Castle Biosciences

Dr. Naresh Gunaratnam interviews Dr. Larry Kim of South Denver GI, where he has spent his career advancing patient care, expanding advanced endoscopy and research programs, and fostering a practice that champions diversity and collaboration in independent GI.







As the 120th president of the American Gastroenterological Association (AGA), Dr. Kim builds on 25 years of leadership advancing research, education, advocacy, and quality initiatives that strengthen the specialty and support gastroenterologists nationwide. He is committed to fostering an inclusive, patient-centered specialty and championing the next generation of GI leaders.



Join Dr. Gunaratnam and Dr. Kim for a conversation about his vision for AGA, the challenges and opportunities ahead for gastroenterology, and how community practice and national leadership intersect to advance patient care.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 81, presented by TissueCypher from Castle Biosciences

Dr. Fred Rosenberg interviews Dr. Reezwana Chowdhury, a gastroenterologist at Johns Hopkins specializing in inflammatory bowel disease (IBD), and Tina Aswani-Omprakash, executive director of the South Asian IBD Alliance.







The South Asian IBD Alliance creates resources, research, and education for IBD patients of South Asian origin and healthcare providers - to minimize disparities, dispel stigma, promote early diagnosis, and improve access to treatment.



Join Dr. Rosenberg, Dr. Chowdhury, and Ms. Aswani‑Omprakash as they explore how physicians independent GI practices can use these tools to provide culturally competent, personalized care, improving outcomes for South Asians living with IBD.



Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC







Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 80, presented by TissueCypher from Castle Biosciences

Dr. Fred Rosenberg interviews Jess Ivy, the Head of Nutrition at Sylvan Health, which focuses on empowering patients with chronic diseases through affordable and accessible nutrition counseling.







Sylvan health provides a comprehensive nutrition service line to support the broader care model within GI practices and to help addresses dietary and lifestyle factors that can play a positive role in digestive health.



Join Dr. Rosenberg and Jess as they explore how independent GI practices can integrate evidence-based nutrition programs into their care plans and potentially improve patient outcomes and reduce costs.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 79, presented by TissueCypher from Castle Biosciences

Dr. Naresh Gunaratnam interviews Dr. Deepti Mehtani, vice president of clinical solutions for NextGen Healthcare, about its recently launched Gastro Suite, which brings gastro-specific workflows to the NextGen electronic health record to streamline repetitive tasks, deliver faster insights, and support an enhanced patient experience.







The suite is easily integrated with other solutions from NextGen Healthcare, enabling hands-free mobile documentation with NextGen Ambient Assist, enhanced patient engagement with the NextGen Closed Loop Patient and Practice Experience, billing automation, cloud hosting, and advanced interoperability.



Join Dr. Gunaratnam and Dr. Mehtani as they explore what independent GI practices should be considering when looking for an industry partner to help improve their data and technology platforms.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 78, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Dr. Brittany Panico, a rheumatologist in Colorado Springs who recently wrote an op-ed calling for reforms to the 340B program to require more transparency and reporting on how 340B discounts are passed on to patients.







The 340B Program is a federal drug pricing program that allows certain hospitals and clinics to buy medications at steep discounts to support medication access for underserved patients, with the expectation that these savings would be passed on to patients.



But critics argue that the program's growth has led to unintended consequences, such as market consolidation. And some studies suggest that 340B discounts may not translate into increased care or lower costs for vulnerable populations.



Join Dr. Mathew and Dr. Panico as they discuss Dr. Panico's experience as an employed physician in a 340B hospital system and as an independent physician, and how the lack of oversight in the program may be making it harder for specialists to deliver the best patient care.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 77, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Vetri Venthan Elango and Dr. Renu Dhanasekaran MD PhD, the founders of Arithmedics, a company that uses generative AI and data intelligence to reduce administrative time and costs for providers.







Arithmedics uses generative AI and data intelligence to reduce billing mistakes and claim denials. Its software generates and explains codes to streamline the billing process and uses data from completed claims to reduce future denials.



Join Dr. Mathew, Dr. Elango and Dr. Dhanasekaran as they discuss what physicians need to understand about implementing AI platforms for administrative tasks such as billing and coding.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 76, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Gary Trendel, vice president of Endoscopy Solutions Ecosystem and Dr. Ruhy Patel, Medical and Scientific Affairs lead for the Endoscopy Solutions Ecosystem and Digital Units at Olympus.



Odin Medical, an Olympus company, recently received 510K clearance from the U.S. Food and Drug Administration for the first cloud-based Artificial Intelligence technology designed to assist gastroenterologists in detecting colorectal polyps during colonoscopy procedures.







The CADDIE, or computer-aided detection (CADe) device, works by analyzing colonoscopy video in real-time and using visual markers to alert the endoscopist to the potential presence of polyps.



A prospective, multi-center randomized controlled trial successfully demonstrated the efficacy and safety of the CADDIE device, underscoring its potential to enhance detection capabilities and patient care without increasing procedural risks or duration.



Join Dr. Mathew, Mr. Trendel, and Dr. Patel as they discuss the potential for AI in improving patient care, and what independent GI physicians should understand about AI platforms that assist in detecting polyps during colonoscopy.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 75, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Jeff Glueck, co-founder and CEO of Salvo Health, a technology company that partners with GI practices to support patients with chronic GI conditions through a virtual clinic experience using a multi-disciplinary care team.







Salvo Health's framework seeks to restore balance and improve chronic symptoms by considering the interconnected roles that the mind, body and gut play in a person's health.



Join Lisa and Jeff as they discuss what GI physicians should consider in partnering with technology platforms that provide cross-functional care to their patients.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 74, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Dr. Vijay Yajnik, vice president and head of U.S. Medical, Gastroenterology, at Takeda about how the prevalence of eosinophilic esophagitis (EoE) is increasing, and evidence is growing that EoE is not a rare disease, but an underdiagnosed one.







Approximately one in 2000 people in the U.S. live with EoE, and the incidence and prevalence of eosinophilic esophagitis have steadily increased over time.



Join Dr. Mathew and Dr. Yajnik as they explore progress that has been made in diagnosing and treating EoE, and some recent studies that could influence patient care.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 73, presented by TissueCypher from Castle Biosciences

Dr. Michael Weinstein interviews Dr. Ali Rezaie, a GI physician-scientist who specializes in microbiome research and gastrointestinal motility disorders.







His recent study, which won an award at ACG, showed that a new elemental diet from mBIOTA Labs can significantly improve patient compliance.



The study assessed mBIOTA Elemental, a palatable elemental diet designed to address the barriers of poor taste and low adherence associated with traditional elemental diets.



Participants using mBIOTA Elemental had complete compliance throughout the two-week therapy, a critical outcome when managing gastrointestinal disorders such as Small Intestinal Bacterial Overgrowth (SIBO), Inflammatory Bowel Disease (IBD), and other complex GI conditions.



Join Dr. Weinstein and Dr. Rezai as they explore how new innovations in elemental diets can help support patients with specific GI conditions and needs.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 72, presented by TissueCypher from Castle Biosciences

Dr. Michael Weinstein interviews Dr. Larry Kosinski about new data from SonarMD describing the association between anxiety and increased risk for flares and higher disease severity in inflammatory bowel disease (IBD), and emphasizing the importance of integrating mental health support within value-based care models for IBD management.







According to the study, patients with anxiety symptoms were significantly more likely to have high disease severity, and over a six-month follow-up, patients with anxiety exhibited a nearly doubled flare rate.



The study suggests that mental health factors like anxiety play a critical role in the clinical course of IBD and that by identifying and addressing psychological contributors, value-based care models can be refined to better support patients with chronic digestive diseases.



Join Dr. Weinstein and Dr. Kosinski as they explore the importance of a multidisciplinary approach to IBD management and what GI physicians can do to ensure that their patients have the resources they need.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 71, presented by TissueCypher from Castle Biosciences

Host Dr. Lisa Mathew interviews Kathleen Teixeira, vice president of public policy and advocacy for the American Gastroenterological Association.







Lisa and Kathleen discuss what policies will be in play in 2025 and how GI physicians can get involved to advocate for their patients and their practices.



Join Lisa and Kathleen as they explore how physicians can get involved in shaping the policies that will affect patient care and practice management with the new Congress and Administration.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 70, presented by TissueCypher from Castle Biosciences

Kevin Harlen interviews Laura Wingate, chief education, support, and advocacy officer with the Crohn's & Colitis Foundation about a recent survey which shows that more than 40 percent of patients with inflammatory bowel disease (IBD) have made significant financial trade-offs to afford their healthcare.







The survey, published in Inflammatory Bowel Diseases, included responses from more than 2,200 IBD patients and caregivers, who highlighted persistent challenges.



Among respondents, 30 percent reported giving up vacations or major household purchases, 22 percent increased their credit card debt, and 21 percent cut back on essential items such as food, clothing, or basic household items.



Join Kevin and Laura as they explore what can done to ensure that IBD patients can access the medications they need without undue financial hardship.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 69, presented by TissueCypher from Castle Biosciences

Dr. Fred Rosenberg interviews Dr. Ruchi Mathur, director of the Diabetes Program in the Division of Endocrinology, Diabetes and Metabolism and an endocrinologist at the Weight Loss Center, at Cedars-Sinai.
Cedars-Sinai recently released a study which found that patients who take a class of widely prescribed medications (GLP-1) to manage diabetes and obesity may require extra preparations before undergoing upper endoscopy procedures.
Join Dr. Rosenberg and Dr. Mathur as they explore how gastroenterologists can advise patients who take GLP-1 medications when preparing for endoscopic procedures, to have the best results.
---
Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC
Mixed and mastered by Hayden Margolis
Gastro Broadcast, Episode 68

Dr. Naresh Gunaratnam interviews Kim Beall, co-founder and managing director of Nutritional Therapy for IBD and Dr. Ashwin Ananthakrishnan, who is the Director of the Massachusetts General Hospital Crohn's and Colitis Center about their work to advance evidence-based nutrition as part of IBD treatment plans.







When nutritional strategies are used in combination with medications, additional pathways are engaged to improve symptoms, quality of life and aid tissue healing.



When patients are able to access evidence-based nutritional therapy under the guidance of a healthcare providers it can them find foods to restore a healthy relationship with food and work their way back to a well-balanced diet of healthy, foods while at the same time feeling well again.



Join Dr. Gunaratnam, Ms. Beall and Dr. Ananthakrishnan as they explore how Nutritional Therapy for IBD works to inform, support, and empower patients and clinicians by providing education and essential tools and resources to utilize nutritional therapy alongside medication.







Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC



Mixed and mastered by Hayden Margolis



Gastro Broadcast, Episode 67, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Dr. Jeff Scott, a gastroenterologist and founder of Happy Colon Foods, a company that prepares meal kits that are compliant with the diet requirements before a colorectal screening.
Happy Colon Foods is designed to mimic a typical day, with three meals and snacks in between, including mac n' cheese and cookies. Because smaller doses of laxatives are spread throughout the day, many patients can work either part or most of their prep day.
A large, randomized trial published in 2013 compared the results of clear-liquid only and low-residue diets, and found that a low-residue diet, is just as effective than a diet restricted to clear liquids.
Join Dr. Mathew and Dr. Scott as they explore how this type of colonoscopy prep can remove some of the difficulty of preparing for a colonoscopy and encourage people to get screened.
-
Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC
Mixed and mastered by Hayden Margolis
Gastro Broadcast, Episode 66, presented by TissueCypher from Castle Biosciences

Dr. Lisa Mathew interviews Dr. Raman Muthusamy, professor of clinical medicine at the David Geffen School of Medicine at UCLA, and medical director of endoscopy for UCLA Health, about a new clinical guideline for endoscopic eradication therapy to prevent the progression of Barrett’s esophagus to esophageal cancer.
Esophageal cancer is preventable if high-risk patients, such as those with Barrett’s Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett’s tissue.
Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate.
Join Dr. Mathew and Dr. Muthusamy as they explore new technologies for identifying patients who are most at risk and the potential innovations that could stop a majority of Barrett’s Esophagus patients from progressing to esophageal cancer.
---
Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC
Mixed and mastered by Hayden Margolis
Gastro Broadcast, Episode 65, presented by TissueCypher from Castle Biosciences

Dr. Fred Rosenberg interviews Dr. Lauren Bleich, of Gastro Health, who serves as president of the Massachusetts Gastroenterology Society about a new blood-based screening test from Guardant Health for colorectal cancer.
This summer, a U.S. Food & Drug Administration advisory panel voted that the Shield test was safe and effective, after reviewing evidence from a study which showed that the test correctly detected colorectal cancer in 83% of people confirmed to have it. However, the panel cautioned that while the test is effective in finding later-stage cancers, it only detected 13% of earlier-stage polyps.
Join Dr. Rosenberg and Dr. Bleich as they discuss the opportunities and limitations of this new test in detecting polyps, and why colonoscopy remains the gold standard for colorectal cancer screening, as the only test that prevents colon cancer by removing polyps before they can turn into cancer.
---
Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC
Mixed and mastered by Hayden Margolis
Gastro Broadcast, Episode 64, presented by TissueCypher from Castle Biosciences